Filed: 2/14/2025ACC: 0000950123-25-002412
📋 What this filing means
BLUE OWL CAPITAL HOLDINGS LP filed this quarterly 13F‑HR report disclosing 78 equity positions with a total reported market value of $434.02M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
78
Positions
$434.02M
Total AUM (reported)
82.33M
Total Shares
Allocation by class
COM$278.21M64.1%
COM SHS$67.78M15.6%
COM SER A$50.45M11.6%
CL A NEW$11.14M2.6%
COM NEW$6.70M1.5%
COM CL A$5.03M1.2%
SPONSORED ADS$4.29M1.0%
Portfolio Concentration
Top 3$148.74M34.3%
4–10$161.51M37.2%
11–25$96.29M22.2%
Rest$27.47M6.3%
Top 3 weight
34.3%
Top 10 weight
71.5%
Voting Authority Distribution
Total shares with voting rights: 0.00
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other78
Dominant voting typeNone · 0.0% of voting shares
Institutional Holdings78
Rows:
NUVEEN CHURCHILL DIRECT LEND
DFNDShares4.04M
TypeSH
Market value$67.78M
15.62%
Sole
0.00
Shared
0.00
None
0.00
KLAVIYO INC
DFNDShares1.08M
TypeSH
Market value$44.49M
10.25%
Sole
0.00
Shared
0.00
None
0.00
PLIANT THERAPEUTICS INC
DFNDShares2.77M
TypeSH
Market value$36.47M
8.40%
Sole
0.00
Shared
0.00
None
0.00
BLUE OWL CAPITAL CORPORATION
DFNDShares2.05M
TypeSH
Market value$30.92M
7.12%
Sole
0.00
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
DFNDShares2.37M
TypeSH
Market value$28.88M
6.65%
Sole
0.00
Shared
0.00
None
0.00
CONDUENT INC
DFNDShares5.63M
TypeSH
Market value$22.73M
5.24%
Sole
0.00
Shared
0.00
None
0.00
TOURMALINE BIO INC
DFNDShares1.08M
TypeSH
Market value$21.89M
5.04%
Sole
0.00
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
DFNDShares3.16M
TypeSH
Market value$21.01M
4.84%
Sole
0.00
Shared
0.00
None
0.00
EVERCOMMERCE INC
DFNDShares1.64M
TypeSH
Market value$18.08M
4.17%
Sole
0.00
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
DFNDShares4.65M
TypeSH
Market value$18.01M
4.15%
Sole
0.00
Shared
0.00
None
0.00
GOHEALTH INC
DFNDShares83.26K
TypeSH
Market value$11.14M
2.57%
Sole
0.00
Shared
0.00
None
0.00
HOLLEY INC
DFNDShares2.99M
TypeSH
Market value$9.03M
2.08%
Sole
0.00
Shared
0.00
None
0.00
ACELYRIN INC
DFNDShares2.78M
TypeSH
Market value$8.74M
2.01%
Sole
0.00
Shared
0.00
None
0.00
ELEDON PHARMACEUTICALS INC
DFNDShares1.96M
TypeSH
Market value$8.07M
1.86%
Sole
0.00
Shared
0.00
None
0.00
DISC MEDICINE INC
DFNDShares120.26K
TypeSH
Market value$7.62M
1.76%
Sole
0.00
Shared
0.00
None
0.00
IKENA ONCOLOGY INC
DFNDShares4.09M
TypeSH
Market value$6.71M
1.55%
Sole
0.00
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
DFNDShares6.36M
TypeSH
Market value$6.68M
1.54%
Sole
0.00
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
DFNDShares1.32M
TypeSH
Market value$5.96M
1.37%
Sole
0.00
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
DFNDShares1.73M
TypeSH
Market value$5.35M
1.23%
Sole
0.00
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares118.24K
TypeSH
Market value$4.97M
1.15%
Sole
0.00
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
DFNDShares667.59K
TypeSH
Market value$4.97M
1.15%
Sole
0.00
Shared
0.00
None
0.00
REPARE THERAPEUTICS INC
DFNDShares3.44M
TypeSH
Market value$4.51M
1.04%
Sole
0.00
Shared
0.00
None
0.00
E2OPEN PARENT HOLDINGS INC
DFNDShares1.65M
TypeSH
Market value$4.39M
1.01%
Sole
0.00
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
DFNDShares2.95M
TypeSH
Market value$4.28M
0.99%
Sole
0.00
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
DFNDShares242.63K
TypeSH
Market value$3.84M
0.88%
Sole
0.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NUVEEN CHURCHILL DIRECT LENDDFND | COM SHS | 4.04M | SH | $67.78M 15.62% | 0.00 | 0.00 | 0.00 |
KLAVIYO INCDFND | COM SER A | 1.08M | SH | $44.49M 10.25% | 0.00 | 0.00 | 0.00 |
PLIANT THERAPEUTICS INCDFND | COM | 2.77M | SH | $36.47M 8.40% | 0.00 | 0.00 | 0.00 |
BLUE OWL CAPITAL CORPORATIONDFND | COM | 2.05M | SH | $30.92M 7.12% | 0.00 | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCDFND | COM | 2.37M | SH | $28.88M 6.65% | 0.00 | 0.00 | 0.00 |
CONDUENT INCDFND | COM | 5.63M | SH | $22.73M 5.24% | 0.00 | 0.00 | 0.00 |
TOURMALINE BIO INCDFND | COM | 1.08M | SH | $21.89M 5.04% | 0.00 | 0.00 | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 3.16M | SH | $21.01M 4.84% | 0.00 | 0.00 | 0.00 |
EVERCOMMERCE INCDFND | COM | 1.64M | SH | $18.08M 4.17% | 0.00 | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCDFND | COM | 4.65M | SH | $18.01M 4.15% | 0.00 | 0.00 | 0.00 |
GOHEALTH INCDFND | CL A NEW | 83.26K | SH | $11.14M 2.57% | 0.00 | 0.00 | 0.00 |
HOLLEY INCDFND | COM | 2.99M | SH | $9.03M 2.08% | 0.00 | 0.00 | 0.00 |
ACELYRIN INCDFND | COM | 2.78M | SH | $8.74M 2.01% | 0.00 | 0.00 | 0.00 |
ELEDON PHARMACEUTICALS INCDFND | COM | 1.96M | SH | $8.07M 1.86% | 0.00 | 0.00 | 0.00 |
DISC MEDICINE INCDFND | COM | 120.26K | SH | $7.62M 1.76% | 0.00 | 0.00 | 0.00 |
IKENA ONCOLOGY INCDFND | COM | 4.09M | SH | $6.71M 1.55% | 0.00 | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCDFND | COM | 6.36M | SH | $6.68M 1.54% | 0.00 | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCDFND | COM SER A | 1.32M | SH | $5.96M 1.37% | 0.00 | 0.00 | 0.00 |
TANGO THERAPEUTICS INCDFND | COM | 1.73M | SH | $5.35M 1.23% | 0.00 | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 118.24K | SH | $4.97M 1.15% | 0.00 | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCDFND | COM NEW | 667.59K | SH | $4.97M 1.15% | 0.00 | 0.00 | 0.00 |
REPARE THERAPEUTICS INCDFND | COM | 3.44M | SH | $4.51M 1.04% | 0.00 | 0.00 | 0.00 |
E2OPEN PARENT HOLDINGS INCDFND | COM CL A | 1.65M | SH | $4.39M 1.01% | 0.00 | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCDFND | COM | 2.95M | SH | $4.28M 0.99% | 0.00 | 0.00 | 0.00 |
KEROS THERAPEUTICS INCDFND | COM | 242.63K | SH | $3.84M 0.88% | 0.00 | 0.00 | 0.00 |
Page 1 of 4